Named as a key player in 33 of our reports, across 33 regions and countries.
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Epilepsy Drugs | Pharmaceuticals | $9.6 Bn | 3.5% |
Named as key players in the same markets as Sunovion Pharmaceuticals Inc. (number of shared markets).
Johnson & Johnson Health Care Systems Inc.1 shared market
Novartis AG1 shared market
Pfizer Inc.1 shared market
Teva Pharmaceutical Industries Ltd.1 shared market
Search all reports for Sunovion Pharmaceuticals Inc. All companies